(Q50803480)

19 March 2018

title

Distribution of intrapleural and intravenous Corynebacterium parvum in humans; 99mTc-, and 131I-labeled bacteria. (English)

1 reference

19 March 2018

author name string

M Kaufmann

1

1 reference

19 March 2018

J Marqverson

2

1 reference

19 March 2018

K E Stanley

3

1 reference

19 March 2018

C Mouritzen

4

1 reference

19 March 2018

H Hvid-Hansen

5

1 reference

19 March 2018

publication date

1 January 1986

1 reference

19 March 2018

Cancer Immunology, Immunotherapy

published in

1 reference

19 March 2018

volume

22

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

56-61

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/bf00205717

exact match

0 references

cites work

Immunologic alterations in bronchogenic cancer. Sequential study

1 reference

12 December 2020

Radiolabelling of Corynebacterium parvum and its distribution in mice

1 reference

12 December 2020

Labeling and distribution of technetium-99m corynebacterium parvum as determined by whole-body imaging

1 reference

12 December 2020

Regional immunotherapy of lung cancer with intrapleural B.C.G

1 reference

12 December 2020

Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer

1 reference

12 December 2020

Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer

1 reference

12 December 2020

Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma

1 reference

12 December 2020

Organ distribution of Corynebacterium parvum labeled with iodine-125

1 reference

12 December 2020

The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity

1 reference

12 December 2020

Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group

1 reference

12 December 2020

Intrapleural BCG in operable lung cancer.

1 reference

12 December 2020

Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group

1 reference

12 December 2020

The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells

1 reference

12 December 2020

Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system

1 reference

12 December 2020

Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection

1 reference

12 December 2020

Organ distribution of technetium-99m-labeled corynebacterium parvum in normal and tumor-bearing mice

1 reference

12 December 2020

The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205717

1 reference

19 March 2018

1 reference

19 March 2018